DE2800919A1 - Piperidinderivate - Google Patents

Piperidinderivate

Info

Publication number
DE2800919A1
DE2800919A1 DE19782800919 DE2800919A DE2800919A1 DE 2800919 A1 DE2800919 A1 DE 2800919A1 DE 19782800919 DE19782800919 DE 19782800919 DE 2800919 A DE2800919 A DE 2800919A DE 2800919 A1 DE2800919 A1 DE 2800919A1
Authority
DE
Germany
Prior art keywords
diphenylmethylene
piperidine
hydroxybenzyl
deep
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19782800919
Other languages
German (de)
English (en)
Inventor
Dusan Dr Zivkovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of DE2800919A1 publication Critical patent/DE2800919A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19782800919 1977-01-11 1978-01-10 Piperidinderivate Withdrawn DE2800919A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB931/77A GB1542823A (en) 1977-01-11 1977-01-11 Piperidine derivatives

Publications (1)

Publication Number Publication Date
DE2800919A1 true DE2800919A1 (de) 1978-07-13

Family

ID=9713045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782800919 Withdrawn DE2800919A1 (de) 1977-01-11 1978-01-10 Piperidinderivate

Country Status (22)

Country Link
JP (1) JPS5387367A (fr)
BE (1) BE862769A (fr)
BG (1) BG28574A3 (fr)
CA (1) CA1101426A (fr)
CS (1) CS195652B2 (fr)
DD (1) DD134089A5 (fr)
DE (1) DE2800919A1 (fr)
DK (1) DK5778A (fr)
ES (1) ES465861A1 (fr)
FI (1) FI780028A (fr)
FR (1) FR2376846A1 (fr)
GB (1) GB1542823A (fr)
IL (1) IL53766A0 (fr)
IT (1) IT1103117B (fr)
LU (1) LU78839A1 (fr)
NL (1) NL7800146A (fr)
NO (1) NO780040L (fr)
PL (1) PL203912A1 (fr)
PT (1) PT67511B (fr)
SE (1) SE7800184L (fr)
SU (2) SU772482A3 (fr)
ZA (1) ZA78158B (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235463A2 (fr) * 1985-12-20 1987-09-09 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Arylalkyl et arylalkylène piperidines substitués sur l'azote utilisés comme agents antihistaminiques cardiovasculaires et antisécrétion
WO1991010651A1 (fr) * 1990-01-06 1991-07-25 Pfizer Limited Agents anticholinergiques
WO1997022583A1 (fr) * 1995-12-20 1997-06-26 Eckhart Pein Nouveaux derives de 1-phenylalkyl/alkylene-4-(.alpha.-hydroxydiphenylmethyl)-piperidine et leur utilisation comme antagonistes de la serotonine
WO1999036405A1 (fr) * 1998-01-16 1999-07-22 Eisai Co., Ltd. Procede de production de derive de donepezil

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650874A (en) * 1984-11-26 1987-03-17 G. D. Searle & Co. N-(aralkoxybenzyl)-4(benzhydryl) piperidines
US4628095A (en) * 1985-06-05 1986-12-09 G. D. Searle & Co. Substituted N-benzyl-4-(benzhydryl) piperidines
AU2003296308A1 (en) * 2002-12-18 2004-07-29 Bayer Cropscience Ag N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
WO2004103972A1 (fr) * 2003-05-20 2004-12-02 Ajinomoto Co.,Inc. Nouveau derive de piperidine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
britische Patentschrift 1 242 169

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235463A2 (fr) * 1985-12-20 1987-09-09 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Arylalkyl et arylalkylène piperidines substitués sur l'azote utilisés comme agents antihistaminiques cardiovasculaires et antisécrétion
EP0235463A3 (fr) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Arylalkyl et arylalkylène piperidines substitués sur l'azote utilisés comme agents antihistaminiques cardiovasculaires et antisécrétion
WO1991010651A1 (fr) * 1990-01-06 1991-07-25 Pfizer Limited Agents anticholinergiques
WO1997022583A1 (fr) * 1995-12-20 1997-06-26 Eckhart Pein Nouveaux derives de 1-phenylalkyl/alkylene-4-(.alpha.-hydroxydiphenylmethyl)-piperidine et leur utilisation comme antagonistes de la serotonine
WO1999036405A1 (fr) * 1998-01-16 1999-07-22 Eisai Co., Ltd. Procede de production de derive de donepezil
US6252081B1 (en) 1998-01-16 2001-06-26 Eisai Co., Ltd. Process for production of donepezil derivative

Also Published As

Publication number Publication date
IL53766A0 (en) 1978-04-30
FI780028A (fi) 1978-07-12
FR2376846B1 (fr) 1983-02-04
JPS6125031B2 (fr) 1986-06-13
NO780040L (no) 1978-07-12
FR2376846A1 (fr) 1978-08-04
PT67511B (fr) 1979-06-11
BG28574A3 (en) 1980-05-15
IT1103117B (it) 1985-10-14
SU990761A1 (ru) 1983-01-23
CS195652B2 (en) 1980-02-29
SE7800184L (sv) 1978-07-12
GB1542823A (en) 1979-03-28
CA1101426A (fr) 1981-05-19
LU78839A1 (fr) 1978-09-18
PL203912A1 (pl) 1979-06-04
BE862769A (fr) 1978-07-10
JPS5387367A (en) 1978-08-01
IT7847573A0 (it) 1978-01-10
NL7800146A (nl) 1978-07-13
ZA78158B (en) 1978-10-25
DK5778A (da) 1978-07-12
PT67511A (fr) 1978-02-01
ES465861A1 (es) 1978-09-16
DD134089A5 (de) 1979-02-07
SU772482A3 (ru) 1980-10-15

Similar Documents

Publication Publication Date Title
DE1543714C3 (de) Basisch substituierte Phthalanverbindungen und Verfahren zu ihrer Herstellung
DD202715A5 (de) Verfahren zur herstellung von substituierten derivaten des pyridazin
DD201903A5 (de) Verfahren zur herstellung von derivaten des thienopyridonons
DE2800919A1 (de) Piperidinderivate
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3438244C2 (fr)
DE2513136C3 (de) N-(1-Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE3007710C2 (de) 5,6;8,9-Tetrahydro-7H-dibenz(d,f)azonin-derivate, Verfahren zu deren Herstellung und Arzneimittel
DE2730593A1 (de) Neue aminoalkoxybenzofurane, verfahren zur herstellung derselben und diese enthaltende pharmazeutische mittel
DE1670622A1 (de) Verfahren zur Herstellung von Aminoalkyl-pyrrol-2-yl-ketonen
DE2034588C3 (de) 6,7-Dimethoxy-4-benzylisochinoline, Verfahren zu ihrer Herstellung und Arzneimittel
DE1922280C3 (de) l-Methyl-5-(3'-dimethylaminopropyliden)-5Hdibenzo [a,d] -cyelohepten-N- oxid und dessen Säureadditionssalze, sowie Verfahren zu deren Herstellung und diese Verbindungen enthaltende Präparate
DE2435816B2 (de) Substituierte nitrobenzophenonderivate, ihre salze, verfahren zur herstellung derselben und arzneimittel
DE1620151B1 (de) 10-Piperazino-dibenzo(a,d)cycloheptadienderivate und Verfahren zu ihrer Herstellung
DD251982A5 (de) Verfahren zur herstellung von neuen in 11-stellung substituierten 5,11-dihydro-6h-pyride-(2,3-b)(1,4) benzodiazipin-6-onen
DE1445416C3 (de) N-substituierte 23-Polymethylenindole, ein Verfahren zu ihrer Herstellung und Arzneimittel
DE2257397C3 (de) Decahydrochinolinolderivate, deren Salze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE3611427A1 (de) Bis-tertiaerbutylamino-substituierte 1,3,5-triazinderivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
DE1645901C3 (de) gamma-(4-Alkylp!peridino)-p-fluorbutyrophenone und Verfahren zu ihrer Herstellung
DE2060903B2 (de) N-oxide der dibenzo eckige klammer auf b,f eckige klammer zu thiepinreihe, verfahren zur herstellung derselben und pharmazeutische mittel
DE1793590C3 (de) N-Cyclopropyl-N-propargyl- 1-aminoindan, dessen Salze und Arzneimittel auf dieser Grundlage. Ausscheidung aus': 1443403
DE1545714C (de) 4 eckige Klammer auf 1 Benzylpipendyl (2) eckige Klammer zu 2,2 diphenyl 1,3 dioxolane und Verfahren zu ihrer Herstellung
DE2215545C3 (de) Pyridin-2-carbonsäurepiperazide
DE1445638C (de) 9 geschweifte Klammer auf gamma eckige Klammer auf N* (beta hydroxyaryl) piperazino eckige Klammer zu propyl geschweifte Klam mer zu 9,10 dihydro 9,10 athano (1,2) anthra zen und seme Salze, Verfahren zu deren Her stellung und pharmazeutisches Mittel
DE2159679C3 (de) Isonipecotinsäurederivate

Legal Events

Date Code Title Description
8141 Disposal/no request for examination